Jonathan Tart

632 total citations
9 papers, 396 citations indexed

About

Jonathan Tart is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Jonathan Tart has authored 9 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Jonathan Tart's work include Protein Kinase Regulation and GTPase Signaling (3 papers), Protease and Inhibitor Mechanisms (3 papers) and Cell Adhesion Molecules Research (2 papers). Jonathan Tart is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (3 papers), Protease and Inhibitor Mechanisms (3 papers) and Cell Adhesion Molecules Research (2 papers). Jonathan Tart collaborates with scholars based in United Kingdom, Australia and Singapore. Jonathan Tart's co-authors include Rose A. Maciewicz, Jon Winter, Julie A. Tucker, Alexander L. Breeze, C. Brassington, Mien Van Hoang, Anthea Messent, Martin J. Humphries, Daniel V. Bax and Francesca Mercuri and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Medicinal Chemistry.

In The Last Decade

Jonathan Tart

9 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Tart United Kingdom 8 283 115 83 58 43 9 396
Mitesh Nagar Canada 10 223 0.8× 68 0.6× 68 0.8× 62 1.1× 24 0.6× 15 420
Gretchen A. Repasky United States 8 403 1.4× 95 0.8× 200 2.4× 18 0.3× 47 1.1× 9 634
Aaron Maurais United States 7 204 0.7× 56 0.5× 71 0.9× 50 0.9× 80 1.9× 8 364
M. Anthony Leesnitzer United States 10 288 1.0× 122 1.1× 179 2.2× 114 2.0× 45 1.0× 11 536
Terry L. Nechuta United States 8 223 0.8× 47 0.4× 49 0.6× 102 1.8× 69 1.6× 9 327
Andrea Uecker Germany 9 207 0.7× 45 0.4× 82 1.0× 32 0.6× 119 2.8× 12 457
Michael Capparelli United States 8 253 0.9× 195 1.7× 211 2.5× 24 0.4× 101 2.3× 9 470
Della White United States 6 284 1.0× 60 0.5× 112 1.3× 21 0.4× 95 2.2× 6 420
Geoff Mellor United Kingdom 5 176 0.6× 105 0.9× 89 1.1× 9 0.2× 67 1.6× 5 357
Andrei Y. Volgin United States 5 166 0.6× 59 0.5× 123 1.5× 19 0.3× 20 0.5× 7 357

Countries citing papers authored by Jonathan Tart

Since Specialization
Citations

This map shows the geographic impact of Jonathan Tart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Tart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Tart more than expected).

Fields of papers citing papers by Jonathan Tart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Tart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Tart. The network helps show where Jonathan Tart may publish in the future.

Co-authorship network of co-authors of Jonathan Tart

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Tart. A scholar is included among the top collaborators of Jonathan Tart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Tart. Jonathan Tart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Davies, Gareth M., Tiziana Monteverde, Jonathan Tart, et al.. (2024). High throughput application of the NanoBiT Biochemical Assay for the discovery of selective inhibitors of the interaction of PI3K-p110α with KRAS. SLAS DISCOVERY. 29(8). 100197–100197. 1 indexed citations
2.
Fletcher, Alice, Dean Clift, Sergio Martínez Cuesta, et al.. (2023). A TRIM21-based bioPROTAC highlights the therapeutic benefit of HuR degradation. Nature Communications. 14(1). 7093–7093. 23 indexed citations
3.
Fumagalli, Gabriele, Rodrigo J. Carbajo, J. Willem M. Nissink, et al.. (2021). Targeting a Novel KRAS Binding Site: Application of One-Component Stapling of Small (5–6-mer) Peptides. Journal of Medicinal Chemistry. 64(23). 17287–17303. 7 indexed citations
4.
Read, Jon, Jonathan Tart, Philip B. Rawlins, et al.. (2019). Rapid Identification of Novel Allosteric PRC2 Inhibitors. ACS Chemical Biology. 14(10). 2134–2140. 9 indexed citations
5.
Winter, Jon, Malcolm Anderson, Kevin Blades, et al.. (2015). Small Molecule Binding Sites on the Ras:SOS Complex Can Be Exploited for Inhibition of Ras Activation. Journal of Medicinal Chemistry. 58(5). 2265–2274. 93 indexed citations
6.
Ward, Richard A., C. Brassington, Alexander L. Breeze, et al.. (2012). Design and Synthesis of Novel Lactate Dehydrogenase A Inhibitors by Fragment-Based Lead Generation. Journal of Medicinal Chemistry. 55(7). 3285–3306. 126 indexed citations
7.
Clements, Kristen M., Jonathan Tart, Sarah Brockbank, et al.. (2011). Matrix metalloproteinase 17 is necessary for cartilage aggrecan degradation in an inflammatory environment. Annals of the Rheumatic Diseases. 70(4). 683–689. 24 indexed citations
8.
Bax, Daniel V., Anthea Messent, Jonathan Tart, et al.. (2004). Integrin α5β1 and ADAM-17 Interact in Vitro and Co-localize in Migrating HeLa Cells. Journal of Biological Chemistry. 279(21). 22377–22386. 69 indexed citations
9.
Mercuri, Francesca, Rose A. Maciewicz, Jonathan Tart, Karena Last, & Amanda Fosang. (2000). Mutations in the Interglobular Domain of Aggrecan Alter Matrix Metalloproteinase and Aggrecanase Cleavage Patterns. Journal of Biological Chemistry. 275(42). 33038–33045. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026